Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Study to Compare Two Diagnostic Tests (1,3-β-D-glucan vs Blood Culture) in Critically Ill Patients With Suspected Invasive CAndidiasis Hospitalized in Internal Medicine Wards and Who Are Currently Timely Treated With Echinocandin (Micafungin)

NCT03906916 is registered in ClinicalTrials.gov with Fadoi Foundation, Italy as lead sponsor.

NCT NCT03906916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03906916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Study to Compare Two Diagnostic Tests (1,3-β-D-glucan vs Blood Culture) in Critically Ill Patients With Suspected Invasive CAndidiasis Hospitalized in Internal Medicine Wards and Who Are Currently Timely Treated With Echinocandin (Micafungin)
Lead sponsor
Fadoi Foundation, Italy
Phase
Phase 4
Overall status
Terminated
Start date
July 18, 2018
Completion date
February 1, 2019
Enrollment
14 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

invasive candidiasis